Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments.Introducing a new discovery about 37366-09-9, Name is Dichloro(benzene)ruthenium(II) dimer, name: Dichloro(benzene)ruthenium(II) dimer.
New ruthenium(II) arene derivatives (arene = p-cymene, benzene, hexamethylbenzene) containing beta-ketoamine ligands L? (HL? in general; in detail, HLph,ph = (4Z)-3-methyl-4-((phenylamino)(phenyl) methylene)-1-phenyl-1H-pyrazol-5(4H)-one, HLnaph,ph = (4Z)-3-methyl-4-((phenyamino)(naphthalen-2-yl)methylene)-1-phenyl-1H-pyrazol- 5(4H)-one, HLet,ph = (4Z)-3-methyl-4-(1-(phenylamino)propylidene)-1- phenyl-1H-pyrazol-5(4H)-one) have been synthesized and characterized by spectroscopy (IR, ESI-MS, 1H and 13C NMR) and elemental analysis. The ligands in the anionic form coordinate ruthenium in a chelating kappa2N,O-bidentate fashion, affording 1:1 derivatives of the formula [Ru(arene)(L?)Cl]. Further reaction of [Ru(p-cymene)(L?)Cl] with AgPF6 or PTA (PTA = 1,3,5-triaza-7-phosphaadamantane) in methanol affords [Ru(p-cymene)(L?)(CH3OH)][PF6] and [Ru(p-cymene)(L?)(PTA)]Cl, respectively. The solid-state structures of the ligand HLet,ph and complexes [Ru(p-cymene)(Lph,ph)Cl] (1), [Ru(p-cymene)(Lnaph,ph)Cl] (4), and [Ru(p-cymene)(L et,ph)Cl] (7) have been determined by single-crystal X-ray diffraction. The antitumor activity of both the ligands and complexes has been evaluated against the human ovarian carcinoma cell line A2780 and its cisplatin-resistant equivalent A2780R, some of the complexes showing significant cytotoxicity toward the cisplatin-resistant cell line.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.name: Dichloro(benzene)ruthenium(II) dimer. In my other articles, you can also check out more blogs about 37366-09-9
Reference：
Highly efficient and robust molecular ruthenium catalysts for water oxidation,
Catalysts | Special Issue : Ruthenium Catalysts – MDPI